| Name |
Atrovent N 20 mikrograma po potisku, stlačeni inhalat, otopina |
| Former Name |
Atrovent N stlačeni inhalat, otopina |
| Marketing Authorisation Number |
HR-H-119167758 |
| Active Substance |
ipratropijev bromid hidrat |
| Composition |
1 odmjerena doza (potiskom preko ventila) sadrži 20 mikrograma ipratropijevog bromida u obliku ipratropijevog bromid hidrata |
| Pharmaceutical Form |
stlačeni inhalat, otopina |
| Manufacturer |
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Njemačka |
| Marketing Authorisation Holder |
Boehringer Ingelheim Zagreb d.o.o., Radnička cesta 75, Zagreb, Hrvatska |
| Marketing Authorisation Date |
21.11.2017 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/13-02/358 |
| Registration Number |
381-12-01/30-17-26 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
R03BB01 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
